Huimin Wang - Edwards Lifesciences Insider

Edwards Lifesciences Corporation -- USA Stock  

USD 120.49  3.42  2.76%

Corporate Vice President Japan, Asia Pacific

Dr. Huimin Wang M.D., is Corporationrationrate Vice President, Japan, Asia Pacific of Edwards Lifesciences Corporationrationration. From 2004 to 2010. Dr. Wang was Corporationrationrate Vice President, Japan, Asia and Pacific since 2010. Previously, he served in a number of roles with Baxter Healthcare Corporationrationration, including Senior Manager of Strategy Development, Director of ProductTherapy for the Renal Division in Japan, President of Medical Systems and Devices in Japan, and was a representative director of Baxter Limited, a Japan corporation, through September 2002. Before joining Baxter, Dr. Wang was a senior associate with Booz, Allen Hamilton in Chicago, Vice President of Integrated Strategies, a consulting and venture management firm he cofounded, and an associate with McKinsey Company. Dr. Wang is a Visiting Associate Professor of anesthesiology at Keio University
Age: 59  President Since 2010  MBA    
949 250-2500  www.edwards.com
Wang earned his Doctor of Medicine degree from Kagoshima University in Japan and was a Resident and Staff Physician in anesthesiology at Keio University Hospital in Tokyo. He earned his MBA from the University of Chicago.

Huimin Wang Latest Insider Activity

Management Efficiency

The company has Return on Asset (ROA) of 12.64 % which means that for every $100 of asset it generated profit of $12.64. This is typical in the industry. Likewise, it shows return on total equity (ROE) of 25.45 % which means that it produced $25.45 on every 100 dollars invested by current stockholders.
The company reports 1.03 B of total liabilities with total debt to equity ratio (D/E) of 32.7 which implies that the company may not be able to produce enough cash to satisfy its debt commitments. Edwards Lifesciences Corporation has Current Ratio of 3.42 indicating that it is in good position to pay out its debt commitments in time.

Similar Executives

Showing few of many executives

PRESIDENT Since

Glen StettinExpress Scripts Holding Company
2015
Alberto MasBecton Dickinson and Company
2016
Linda TharbyBecton Dickinson and Company
2016
Everett NevilleExpress Scripts Holding Company
2015
Don FotschExpress Scripts Holding Company
2015
James ClearyAmerisourceBergen Corporation
2015
Clare TrachtmanBaxter International Inc
2015
Jill SchaafBaxter International Inc
2015
Sun ParkAmerisourceBergen Corporation
2016
Martin AkinsExpress Scripts Holding Company
2015
Neal SampleExpress Scripts Holding Company
2016
Barbara BrungessAmerisourceBergen Corporation
N/A
Lawrence MarshAmerisourceBergen Corporation
2014
Marcus SchabackerBaxter International Inc
2015
Gary WimberlyExpress Scripts Holding Company
2007
Keri MattoxAmerisourceBergen Corporation
2017
Christine HoustonExpress Scripts Holding Company
2016
Giuseppe AccogliBaxter International Inc
2017
Lazarus KrikorianAmerisourceBergen Corporation
2014
Phyllis AndersonExpress Scripts Holding Company
2015
Peyton HowellKorenAmerisourceBergen Corporation
2014

Entity Summary

Edwards Lifesciences Corporationration offer solutions and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Lifesciences Corporation (EW) is traded on New York Stock Exchange in USA. It is located in CALIFORNIA, U.S.A and employs 9,800 people. Edwards Lifesciences is listed under Medical Equipment category by Fama And French industry classification.

Did you try this?

Run Price Exposure Probability Now
   

Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
Hide  View All  NextLaunch Price Exposure Probability
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Edwards Lifesciences Corporation to your portfolio

Top Management

Edwards Lifesciences Leadership Team
John Cardis, Director
Wesley Schack, Director, MBA
Larry Wood, VP, MBA
Nicholas Valeriani, Director, MBA
Leslie Heisz, Director, MBA
Catherine Szyman, President, MBA
Martha Marsh, Director, MBA
Huimin Wang, President, MBA
Barbara McNeil, Director, Ph.D
Steven Loranger, Director
William Link, Director
Scott Ullem, CFO, MBA
Patrick Verguet, VP, Ph.D
Kieran Gallahue, Director, MBA
Bernard Zovighian, President, MBA
David Erickson, President
Donald Bobo, VP
Michael Mussallem, Chairman, Ph.D

Stock Performance

Edwards Lifesciences Performance Indicators